Correction: Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma

Lignende værker

• Correction: Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma.
  af: June Y Hou, et al.
  Udgivet: (2016-01-01)
• Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma
  af: Hou, June Y., et al.
  Udgivet: (2013)
• A Novel Indication for Panobinostat as a Senolytic Drug in NSCLC and HNSCC
  af: Samaraweera, Leleesha, et al.
  Udgivet: (2017)
• Potentiation of Taxol Efficacy by Discodermolide in Ovarian Carcinoma Xenograft-Bearing Mice
  af: Huang, Gloria S., et al.
  Udgivet: (2006)
• Selective Potentiation of Paclitaxel (Taxol)-Induced Cell Death by Mitogen-Activated Protein Kinase Kinase Inhibition in Human Cancer Cell Lines
  af: McDaid, Hayley M., et al.
  Udgivet: (2001)